Trial Profile
A study of the effects of etoposide phosphate/cisplatin on endobronchial tumour cell apoptosis in non-small cell lung cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 28 Jul 2005
Price :
$35
*
At a glance
- Drugs Etoposide phosphate (Primary) ; Cisplatin
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 28 Jul 2005 New trial record.